We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+7.89%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$314B
AUM Growth
+$19.1B
(+6.5%)
Cap. Flow
+$92.3M
Cap. Flow
% of AUM
0.03%
Top 10 Holdings %
Top 10 Hldgs %
20.84%
Holding
3,440
New
118
Increased
1,247
Reduced
1,874
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$905M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$585M |
| 3 |
Cisco
CSCO
|
+$554M |
| 4 |
International Flavors & Fragrances
IFF
|
+$456M |
| 5 |
Mastercard
MA
|
+$392M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.37B |
| 2 |
DuPont de Nemours
DD
|
+$556M |
| 3 |
Qualcomm
QCOM
|
+$405M |
| 4 |
Merck
MRK
|
+$333M |
| 5 |
TSMC
TSM
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.31% |
| 2 | Consumer Discretionary | 12.98% |
| 3 | Financials | 12.81% |
| 4 | Healthcare | 12.54% |
| 5 | Communication Services | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CVLY
3001
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $639K | ﹤0.01% |
34,745
-1,262
| -4% | -$21.9K |
|
|
CALA
3002
DELISTED
Calithera Biosciences, Inc
CALA
| $639K | ﹤0.01% |
13,200
-311
| -2% | -$18.1K |
|
3003
VolitionRx Ltd
VNRX
$9.34M
| $634K | ﹤0.01% |
8,394
+405
| +5% | +$34.7K |
|
|
DZSI
3004
DELISTED
DZS Inc. Common Stock
DZSI
| $634K | ﹤0.01% |
40,765
-1,048
| -3% | -$17.4K |
|
3005
Fennec Pharmaceuticals
FENC
$402M
| $630K | ﹤0.01% |
101,369
-4,680
| -4% | -$35.2K |
|
3006
Mastech Digital
MHH
$93.2M
| $630K | ﹤0.01% |
35,797
-488
| -1% | -$8.34K |
|
|
ABTC
3007
American Bitcoin Corp
ABTC
$471M
| $627K | ﹤0.01% |
4
+2
| +100% | +$356K |
|
|
LBC
3008
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $625K | ﹤0.01% |
52,876
-12,870
| -20% | -$138K |
|
3009
First Northwest Bancorp
FNWB
$104M
| $624K | ﹤0.01% |
37,583
-1,125
| -3% | -$18.6K |
|
3010
Riverview Bancorp
RVSB
$108M
| $623K | ﹤0.01% |
89,806
-2,563
| -3% | -$15.7K |
|
|
LJPC
3011
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $620K | ﹤0.01% |
146,256
-12,851
| -8% | -$70.8K |
|
3012
Norwood Financial Corp
NWFL
$368M
| $618K | ﹤0.01% |
23,251
-589
| -2% | -$15.3K |
|
3013
Revolve Group
RVLV
$1.73B
| $617K | ﹤0.01% |
13,731
+3,727
| +37% | +$152K |
|
3014
Chemung Financial Corp
CHMG
$392M
| $612K | ﹤0.01% |
14,640
-416
| -3% | -$15.6K |
|
3015
Xeris Biopharma Holdings
XERS
$1.45B
| $612K | ﹤0.01% |
135,618
-12,794
| -9% | -$69K |
|
3016
Electromed
ELMD
$349M
| $611K | ﹤0.01% |
57,906
+11,820
| +26% | +$128K |
|
3017
Harrow
HROW
$1.51B
| $608K | ﹤0.01% |
90,102
-4,073
| -4% | -$33.4K |
|
|
SRT
3018
DELISTED
Startek Inc.
SRT
| $601K | ﹤0.01% |
75,650
+340
| +0.5% | +$2.82K |
|
3019
Bankwell Financial Group
BWFG
$533M
| $598K | ﹤0.01% |
22,173
+8,234
| +59% | +$190K |
|
3020
Evolution Petroleum
EPM
$131M
| $597K | ﹤0.01% |
176,732
+50,478
| +40% | +$174K |
|
|
FINV
3021
FinVolution Group
FINV
$1.15B
| $595K | ﹤0.01% |
84,853
-9,300
| -10% | -$49.5K |
|
|
INBX
3022
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $595K | ﹤0.01% |
29,620
-3,198
| -10% | -$93.4K |
|
3023
Universal Technical Institute
UTI
$1.59B
| $594K | ﹤0.01% |
101,749
-1,494
| -1% | -$9.22K |
|
3024
Information Services Group
III
$251M
| $590K | ﹤0.01% |
134,000
-25,036
| -16% | -$96.1K |
|
3025
iRadimed
IRMD
$1.18B
| $590K | ﹤0.01% |
22,887
-639
| -3% | -$15.3K |
|
Similar funds
VFT
Nuveen's Q1 2021 Portfolio in Review
As of Q1 2021, Nuveen held 3,440 positions worth $314B, up 6.5% from $295B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Nuveen's Q1 2021 filing shows 118 new, 1,247 increased, 1,874 reduced and 82 closed positions. Its largest new stake was Coupang: 6,313,287 shares worth $312M. The largest sale was Apple, an estimated $1.37B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- Nuveen's largest Q1 2021 buy was Coupang: 6,313,287 shares worth $312M.
- Nuveen added most to Intel in Q1 2021, an estimated $905M increase.
- Nuveen's biggest Q1 2021 reduction was Apple, cutting an estimated $1.37B.
- Nuveen fully exited PARSLEY ENERGY INC in Q1 2021, selling an estimated $122M.
- Nuveen's ten largest holdings make up 21% of its $314B portfolio in Q1 2021.
- Nuveen opened 118 new positions and closed 82 in Q1 2021.
- Nuveen's portfolio value rose 6.5% quarter-over-quarter to $314B.
Based on Nuveen's 13F filing for Q1 2021, filed 17 May 2021.